Title: | AarogyaAI® Rapid Tuberculosis Drug Sensitivity Test |
Area: | Medical Sciences |
Focus Area: | COPD, Healthcare |
Status: | Pilot Study completed |
Social Benefits: | There is a dearth of tools in the market that can provide a rapid and comprehensive diagnosis of drug-resistant tuberculosis. Hence, AarogyaAI®’s algorithm is extremely relevant as it provides a comprehensive precision drug susceptibility report for the patients, based on the genome of the M. tb infecting the patient. |
Developing Agency: | AarogyaAI Innovations Private Limited:, Bangalore, Karnataka |
Technology Readiness Index: | TRL-8 |
Source Title: | Data sourced from Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT) |